3Seliger B,Rongcun Y,Atkins D,et al. HER-2/neu is expressed in human renal cell carcinoma at hetero-geneous levels independently of tumor grading and can be recognized by HLA-Az. 1-restricted cytotuxic T lymphocytes. Int J Cancer,2000,87 (3) :349-359.
5Tan M,Li P,Klos KS,et al. ErbB2 promotes Src synthesis and stability:novel mechanisms of Src activation that confer breast cancer metastasis. Cancer Res ,2005,65 ( 5 ) : 1855-1867.
7Skopelitou A, Kamina S, Krikoni O, et al. p53 DO-1 immunohistochemical overexpression in premalignant and malignant cervlial lesion. Anti Cancer Res,1997,17(1A) :268-275.
8Ambrosini G, Adida C, Altieri DC. A novel anti-apoptosisgene, survivin, expression in cancer and lymphoma. NatMed, 1997,3 ( 8 ) : 917-921.
9Ikehara M,Oshita F,Kaneda Y,et al. Expression of survivin correlated with vessel invasion is a marker of poor prognosis in small adenocarcinoma of the lung. Oncol Rep,2002,9(4) :835-838.
10Adida C, Berrebi D, Peuchmaur M, et al. Anti-apoptosis gene, survivin, and prognosis of neuroblastoma. Lancet, 1998,351:882.
5Silva JM, Dominguez G, Garcia JM, et al. Presence of tumor DNA in plasma of breast cancer patients: elinicopathological correla- tions. Cancer Res, 1999,59 (13) :3251-3256.
6Lamb P,Crawford L. Characterization of the human p53 gene. Mol Cell Biol,1986,6(5) :1379-1385.
